3.7.2025 09:01:35 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state An extraordinary general meeting of Aqua Bio Technology ASA (the "Company" or "ABTEC") will be held on 25 July 2025 at 11:00 (CET) at ABT´s office in Bygdøy Alle 3, Oslo. Please find attached the notice to the general meeting. All documents to be treated at the meeting will be made available at the Company's website www.aquabiotechnology.com - http://www.aquabiotechnology.com - http://www.aquabiotechnology.com - http://www.aquabiotechnology.com. Shareholders who wish to the attend the general meeting is requested to notify the Company as set out in Appendix 2 to the notice within 23 July 2025 at 16:00 (CET). In case of attendance by proxy, the proxy form (also included in appendix 2 to the notice) is requested submitted to be received by the Company within the same date. DISCLOSURE REGULATION This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act. CONTACTS * Roger Sedal, Chair of the Board of Directors, Aqua Bio Technology ASA, +4740002002, roger@sedal.no * Terje Blytt, JetCarrier AS, +4769184030 ABOUT AQUA BIO TECHNOLOGY ASA Aqua Bio Technology ASA (ABT) is a distribution group in skincare and nonfood. The group has distribution towards B2C, B2B, B2B2, and freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock Exchange. ATTACHMENTS Download announcement as PDF.pdf - https://kommunikasjon.ntb.no/ir-files/17847556/18589596/6274/Download%20announce ment%20as%20PDF.pdf WEB Aqua Bio Technology.pdf - https://kommunikasjon.ntb.no/ir-files/17847556/18589596/6273/WEB%20Aqua%20Bio%20 Technology.pdf
Recent Comments